Jerusalem, Israel — March 26, 2020
Access to coronavirus research news and funding opportunities can expand scholarly efforts to understand and contend with COVID-19
Jerusalem, Israel—March 26, 2020. Ex Libris, a ProQuest company, is offering free access to all Research Professional® news coverage related to COVID-19 and relevant funding opportunities related to the pandemic through its Research Professional and Pivot funding databases.
“We would like to do everything we can to contribute to the ongoing scholarly endeavors to combat the coronavirus pandemic,” noted Eyal Kirshner, vice president of research funding and reference solutions at Ex Libris. “By providing free access to rich resources, we hope to help researchers develop much-needed solutions in this difficult battle.”
Free access will include:
- Important coronavirus-related news, available for free on the Research Professional News website.
- A curated list of relevant funding opportunities related to COVID-19 from a variety of global funders, downloadable as a PDF file. Opportunities are continuously updated by the Research Professional and Pivot teams.
“The unique nature of the current pandemic requires organizations around the world to intensify their efforts to share knowledge,” noted Kirshner. “Ex Libris is focused on enabling researchers to gain access to relevant funding opportunities from funders around the world and to continuously obtain the most timely and trusted information.”
About Ex Libris
Ex Libris, a ProQuest company, is a leading global provider of cloud-based SaaS solutions that enable institutions and their individual users to create, manage, and share knowledge. In close collaboration with its customers and the broader community, Ex Libris develops creative solutions that increase library productivity, maximize the impact of research activities, enhance teaching and learning, and drive student mobile engagement. Ex Libris serves over 7,500 customers in 90 countries. For more information, see our website and join us on LinkedIn, YouTube, Facebook, and Twitter.
